Stop overpaying for GLP-1s.

Compare every telehealth provider, compounding pharmacy, and pricing option in one place. Real prices. Real reviews. No sponsored rankings.

Brand-Name (No Insurance)
$1,000+/mo
Ozempic, Wegovy, Zepbound retail
Compounded Alternative
$79/mo
Same active ingredient, licensed pharmacy
You Could Save
$500+/mo
By comparing before you commit
How It Works

Three steps to the right provider at the right price.

01

Pick your medication

Semaglutide, tirzepatide, Ozempic, Wegovy, Zepbound, Mounjaro. Brand or compounded. Injectable or oral.

02

Enter your state

Provider availability, pharmacy licensing, and pricing all vary by state. We show you what's actually available where you are.

03

Compare and decide

Side-by-side pricing, verified patient reviews, pharmacy accreditation status, and safety ratings. No guesswork.

Built for trust, not commissions.

🔍

Transparent Provider Rankings

No pay-to-play. Rankings are based on pricing, patient reviews, and pharmacy quality. Providers cannot buy their way to the top.

Pharmacy Verification

Every compounding pharmacy is checked for state licensing, accreditation status, and sourcing transparency. The #1 safety concern, solved.

💬

Verified Patient Reviews

Structured reviews covering onboarding, shipping, medication quality, provider communication, and weight loss outcomes. Not just star ratings.

⚠️

Safety Watchdog

We flag red flags: research peptides, unlicensed pharmacies, misleading pricing, and experimental drugs. Your safety filter for the GLP-1 wild west.

Medications Covered

Every GLP-1 option, one search.

Semaglutide
Tirzepatide
Ozempic
Wegovy
Wegovy Pill
Zepbound
Mounjaro

Compounded and brand-name. Cash-pay and insurance routes. Injectable and oral. All in one place.

25 million Americans will be on GLP-1s by 2030. Most will overpay.

The GLP-1 market is a $70 billion maze of telehealth ads, confusing pricing, and unverified claims. DoseGuide exists so you don't have to navigate it alone.